E. J. Cone

2.7k total citations · 1 hit paper
24 papers, 2.1k citations indexed

About

E. J. Cone is a scholar working on Toxicology, Pharmacology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, E. J. Cone has authored 24 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Toxicology, 11 papers in Pharmacology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in E. J. Cone's work include Forensic Toxicology and Drug Analysis (17 papers), Cannabis and Cannabinoid Research (10 papers) and Opioid Use Disorder Treatment (6 papers). E. J. Cone is often cited by papers focused on Forensic Toxicology and Drug Analysis (17 papers), Cannabis and Cannabinoid Research (10 papers) and Opioid Use Disorder Treatment (6 papers). E. J. Cone collaborates with scholars based in United States, Bulgaria and Morocco. E. J. Cone's co-authors include Kenzie L. Preston, George E. Bigelow, Maxine L. Stitzer, Sharon Walsh, Marilyn A. Huestis, W. D. Darwin, Barry Levine, Rolley E. Johnson, Marilyn A. Huestis and Yale H. Caplan and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, Journal of Forensic Sciences and Journal of Analytical Toxicology.

In The Last Decade

E. J. Cone

23 papers receiving 1.9k citations

Hit Papers

Clinical pharmacology of buprenorphine: Ceiling effects a... 1994 2026 2004 2015 1994 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. J. Cone United States 20 911 766 644 323 323 24 2.1k
John Mendelson United States 31 761 0.8× 725 0.9× 664 1.0× 424 1.3× 423 1.3× 71 2.8k
Kim Wolff United Kingdom 28 537 0.6× 553 0.7× 503 0.8× 236 0.7× 434 1.3× 120 2.4k
W. D. Darwin United States 36 432 0.5× 1.6k 2.2× 1.2k 1.9× 415 1.3× 178 0.6× 60 3.2k
Yale H. Caplan United States 28 381 0.4× 1.2k 1.6× 381 0.6× 330 1.0× 123 0.4× 97 2.5k
Jermaine D. Jones United States 25 1.0k 1.1× 285 0.4× 336 0.5× 242 0.7× 630 2.0× 79 2.2k
A. Hamid Ghodse United Kingdom 27 429 0.5× 691 0.9× 401 0.6× 125 0.4× 441 1.4× 79 1.9k
George E. Bigelow United States 14 932 1.0× 158 0.2× 375 0.6× 330 1.0× 601 1.9× 16 1.6k
Charles W. Gorodetzky United States 26 460 0.5× 342 0.4× 306 0.5× 502 1.6× 190 0.6× 66 2.0k
Paul J. Fudala United States 30 1.7k 1.9× 200 0.3× 543 0.8× 591 1.8× 1.0k 3.2× 60 3.0k
Richard B. Resnick United States 19 481 0.5× 285 0.4× 301 0.5× 338 1.0× 294 0.9× 44 1.6k

Countries citing papers authored by E. J. Cone

Since Specialization
Citations

This map shows the geographic impact of E. J. Cone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. J. Cone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. J. Cone more than expected).

Fields of papers citing papers by E. J. Cone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. J. Cone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. J. Cone. The network helps show where E. J. Cone may publish in the future.

Co-authorship network of co-authors of E. J. Cone

This figure shows the co-authorship network connecting the top 25 collaborators of E. J. Cone. A scholar is included among the top collaborators of E. J. Cone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. J. Cone. E. J. Cone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cone, E. J., Rebecca Heltsley, David L. Black, et al.. (2013). Prescription Opioids. II. Metabolism and Excretion Patterns of Hydrocodone in Urine Following Controlled Single-Dose Administration. Journal of Analytical Toxicology. 37(8). 486–494. 33 indexed citations
2.
Smith, Michael L., Eric T. Shimomura, Bindu D. Paul, et al.. (2010). Urinary Excretion of Ecgonine and Five Other Cocaine Metabolites Following Controlled Oral, Intravenous, Intranasal, and Smoked Administration of Cocaine. Journal of Analytical Toxicology. 34(2). 57–63. 22 indexed citations
3.
Black, David L., et al.. (2009). Multiple Drug Ingestion by Ecstasy Abusers in the United States. Journal of Analytical Toxicology. 33(3). 143–147. 6 indexed citations
4.
Cone, E. J., Yale H. Caplan, David L. Black, T. Robert, & F. Moser. (2008). Urine Drug Testing of Chronic Pain Patients: Licit and Illicit Drug Patterns. Journal of Analytical Toxicology. 32(8). 530–543. 69 indexed citations
5.
Cone, E. J., Joe T.R. Clarke, & Lolita Tsanaclis. (2007). Prevalence and Disposition of Drugs of Abuse and Opioid Treatment Drugs in Oral Fluid. Journal of Analytical Toxicology. 31(8). 424–433. 53 indexed citations
6.
Huestis, Marilyn A. & E. J. Cone. (2004). Relationship of  9-Tetrahydrocannabinol Concentrations in Oral Fluid and Plasma after Controlled Administration of Smoked Cannabis. Journal of Analytical Toxicology. 28(6). 394–399. 162 indexed citations
7.
Cone, E. J., et al.. (2003). Oxycodone Involvement in Drug Abuse Deaths: A DAWN-Based Classification Scheme Applied to an Oxycodone Postmortem Database Containing Over 1000 Cases. Journal of Analytical Toxicology. 27(2). 57–67. 78 indexed citations
8.
Jenkins, Abigail, Robert M. Keenan, Jack E. Henningfield, & E. J. Cone. (2002). Correlation Between Pharmacological Effects and Plasma Cocaine Concentrations after Smoked Administration. Journal of Analytical Toxicology. 26(7). 382–392. 40 indexed citations
9.
Cone, E. J., Michael Lehrer, Melissa Smith, et al.. (2002). Oral Fluid Testing for Drugs of Abuse: Positive Prevalence Rates by Intercept  Immunoassay Screening and GC-MS-MS Confirmation and Suggested Cutoff Concentrations. Journal of Analytical Toxicology. 26(8). 541–546. 88 indexed citations
10.
Smith, Michael L., Eric T. Shimomura, Bindu D. Paul, et al.. (2001). Urinary Excretion Profiles for Total Morphine, Free Morphine, and 6-Acetylmorphine Following Smoked and Intravenous Heroin. Journal of Analytical Toxicology. 25(7). 504–514. 36 indexed citations
11.
Wilkins, Diana G., et al.. (1999). A Retrospective Study of Buprenorphine and Norbuprenorphine in Human Hair After Multiple Doses. Journal of Analytical Toxicology. 23(6). 409–415. 18 indexed citations
12.
Kuhlman, James J., Seema R. Lalani, Joseph Magluilo, et al.. (1996). Human Pharmacokinetics of Intravenous, Sublingual, and Buccal Buprenorphine. Journal of Analytical Toxicology. 20(6). 369–378. 218 indexed citations
13.
Smith, Michael L., Robert Hughes, Barry Levine, et al.. (1995). Forensic Drug Testing for Opiates. VI. Urine Testing for Hydromorphone, Hydrocodone, Oxymorphone, and Oxycodone with Commercial Opiate Immunoassays and Gas Chromatography-Mass Spectrometry. Journal of Analytical Toxicology. 19(1). 18–26. 55 indexed citations
14.
Foster, Gregory H., et al.. (1995). Selecting an Appropriate Isotopic Internal Standard for Gas Chromatography/Mass Spectrometry Analysis of Drugs of Abuse—Pentobarbital Example. Journal of Forensic Sciences. 40(6). 983–989. 34 indexed citations
15.
Walsh, Sharon, Kenzie L. Preston, Maxine L. Stitzer, E. J. Cone, & George E. Bigelow. (1994). Clinical pharmacology of buprenorphine: Ceiling effects at high doses. Clinical Pharmacology & Therapeutics. 55(5). 569–580. 618 indexed citations breakdown →
16.
Goldberger, Bruce A., E. J. Cone, Therese M. Grant, et al.. (1994). Disposition of Heroin and Its Metabolites in Heroin-Related Deaths. Journal of Analytical Toxicology. 18(1). 22–28. 107 indexed citations
17.
Pickworth, Wallace B., et al.. (1993). Subjective and physiologie effects of intravenous buprenorphine in humans. Clinical Pharmacology & Therapeutics. 53(5). 570–576. 78 indexed citations
18.
Kato, Kenichi, et al.. (1993). Cocaine and Metabolite Excretion in Saliva under Stimulated and Nonstimulated Conditions. Journal of Analytical Toxicology. 17(6). 338–341. 73 indexed citations
19.
Henningfield, Jack E., et al.. (1992). Characterization of the absorption phase of marijuana smoking. Clinical Pharmacology & Therapeutics. 52(1). 31–41. 101 indexed citations
20.
Cone, E. J., R. E. Johnson, Bindu D. Paul, Leroy D. Mell, & J. Mitchell. (1988). Marijuana-Laced Brownies: Behavioral Effects, Physiologic Effects, and Urinalysis in Humans Following Ingestion. Journal of Analytical Toxicology. 12(4). 169–175. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026